Search Within

MSK Grad Students

  1. "Sarcoma Service"
Formats
  1. Journal Article (40)
  2. Meeting Abstract (22)
  3. Review (2)
Groups
  1. Department of Medicine (64)
  2. Sarcoma Service (64)
  3. Solid Tumor Oncology Division (64)
  4. GSK Faculty (56)
  5. Tow Center for Developmental Oncology (TCDO) (53)
  6. Human Oncology and Pathogenesis Program (46)

More Groups

People
  1. Ping Chi (39)
  2. William Tap (28)
  3. Yu Chen (27)
  4. Cristina Antonescu (25)
  5. Samuel Singer (22)
  6. Ciara Kelly (17)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (16)
  5. 2021 (5)
  6. 2020 (3)

More Years

Publications
  1. Clinical Cancer Research (11)
  2. Cancer Research (9)
  3. Annals of Oncology (4)
  4. Cancer Discovery (4)
  5. Journal of Clinical Oncology (4)
  6. Nature Communications (3)

More Publications

Publishers
  1. American Association for Cancer Research (24)
  2. Nature Publishing Group (9)
  3. American Society of Clinical Oncology (5)
  4. Cell Press (5)
  5. Oxford University Press (5)
  6. American Society for Clinical Investigation (2)

More Publishers

Results (64)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: Mutational signature analysis and immunotherapy response
    Journal Article

    Kasago, I. S.; Chatila, W. K.; Lezcano, C. M.; Febres-Aldana, C. A.; Schultz, N.; Vanderbilt, C.; Dogan, S.; Bartlett, E. K.; D'Angelo, S. P.; Tap, W. D.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Histology-specific prognostication for radiation-associated soft tissue sarcoma
    Journal Article

    Bartlett, E. K.; Sharma, A.; Seier, K.; Antonescu, C. R.; Agaram, N. P.; Jadeja, B.; Rosenbaum, E.; Chi, P.; Brennan, M. F.; Qin, L. X.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Tumor-intrinsic PRC2 inactivation drives a context-dependent immune-desert tumor microenvironment
    Meeting Abstract

    Yan, J.; Chen, Y.; Patel, A. J.; Lee, C. J.; Warda, S.; Nixon, B. G.; Wong, E. W. P.; Miranda-Román, M. A.; Yang, N.; Wang, Y.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets
    Meeting Abstract

    Tang, F.; Xu, D.; Wang, S.; Wong, C. K.; Martinez-Fundichely, A.; Lee, C.; Cohen, S.; Park, J.; Hill, C.; Eng, K.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Inactivation mutations of KMT2C/D license a molecular "field effect" and prime the urothelium for tumorigenesis
    Meeting Abstract

    Wang, N.; Pachai, M. R.; Li, D.; Lee, C.; Warda, S.; Xie, G.; Qian, C.; Wong, W. P. E.; Yan, J.; Hu, W.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • PRC2 inactivating mutations amplify cell death in response to DNMT1-targeted therapy through enhanced viral mimicry in malignant peripheral nerve sheath tumor
    Meeting Abstract

    Chi, P.; Patel, A. J.; Warda, S.; Maag, J. L. V.; Misra, R.; Miranda-Román, M. A.; Pachai, M. R.; Lee, C. J.; Li, D.; Wang, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Management of pelvic sarcoma
    Review

    Lee, J. S.; Kelly, C. M.; Bartlett, E. K.
    European Journal of Surgical Oncology (2022)

    Fulltext@MSK | Save